株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の感染症分子診断薬市場:将来の市場動向、サプライヤーの市場シェア、新規技術、競争環境

2016 U.S. Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

発行 Venture Planning Group 商品コード 308583
出版日 ページ情報 英文 636 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。

Local License: 同一事業所内

Back to Top
米国の感染症分子診断薬市場:将来の市場動向、サプライヤーの市場シェア、新規技術、競争環境 2016 U.S. Infectious Disease Molecular Diagnostics Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
出版日: ページ情報: 英文 636 Pages
概要

当レポートでは、米国における感染症向け分子診断薬市場について分析し、技術・市場の最新状況や、市場規模・シェアの動向(今後5年間分)、将来的な市場機会、想定される市場リスク、主要企業のプロファイルなどの情報をお届けいたします。

イントロダクション

世界市場の傾向と新規技術

  • DNAシーケンシング
  • DNA・RNAプローブ技術
  • 検知技術
  • 医療機器:自動/半自動解析装置の分析
  • バイオチップ:遺伝子センサー・マイクロアレイ・ラブオンチップ
  • 薬理ゲノミクス
  • 主な感染症の分子検査方法(全33種)
    • AIDS(後天性免疫不全症候群)
      • 背景事情
      • 診断検査
      • ワクチン・治療薬
    • アデノウイルス/アデノ関連ウイルス(AAV)
    • 炭疽病
    • バベシア症
    • BEAおよびその他のバルトネラ病
    • シャーガス病
    • カンピロバクター
    • クラミジア
    • クロイツェル・ヤコブ病
    • サイトメガロウイルス
    • エボラウイルス
    • エコーウイルス
    • 脳炎
    • エンテロウイルス
    • エプスタイン・バー(EB)ウイルス
    • 淋病
    • A・B・C・D・E・G型肝炎
    • 単純ヘルペスウイルス
    • レジオネラ
    • ライム病
    • マラリア
    • マイコプラズマ
    • パピロマウイルス(HPV)
    • パルボウイルスB19
    • 肺炎
    • ポリオーマウイルス
    • サルモネラ菌
    • 細菌性赤痢
    • 連鎖球菌A・B
    • トキソプラスマ症
    • 結核
    • 西ナイルウイルス
    • エルセニア
  • 競合/保管技術
  • 世界市場の概況
    • ビジネス環境
    • 市場構造
    • 市場規模・成長率

米国市場

  • エグゼクティブ・サマリー
  • ビジネス環境
  • 市場構造
  • 市場のダイナミクス・傾向・規模・成長率
    • 市場規模の予測値:検査項目・市場分野別
    • 売上高の予測値:検査項目・市場分野別
    • 主要サプライヤーの売上高と市場シェア

主な製品開発の機会

  • 新たな医療機器の市場機会
  • 新たな試薬キット・検査装置/パネルの市場機会
  • 新規IT・コンピューター・ソフトウェア・自動化の市場機会
  • 新たな付属装置の市場機会

分散検査製品の設計基準

代替的な市場普及戦略

潜在的な参入障壁とリスク

企業プロファイル

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotes
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • 栄研化学
  • Enzo
  • Exact Sciences
  • 富士レビオ/Innogenetics
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • 島津製作所
  • Siemens
  • Sierra Molecular
  • タカラバイオ
  • Tecan Group

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPMD20951

The report is available by section, market segment, individual test, and can be custom-tailored to your specific information needs and budget.

This new study from VPGMarketResearch contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.

Report Highlights

- Business and technological trends in major markets
Five-year test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Strategic profiles of leading market players and start-up firms developing innovative products
Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the infectious disease molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

US Market Overview

- Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment.

- Five-year test volume and sales projections.

Market Segmentation Analysis

- Sales and market shares of leading suppliers of infectious disease molecular diagnostic   reagent kits and components.

- Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays.

- A comprehensive analysis of the sequencing market by country and laboratory segment.

- Detailed market segmentation analysis, including review of the market dynamics, trends,   structure, size, growth and major suppliers.

Product/Technology Review

- Comparison of leading infectious disease molecular diagnostic analyzers.

- Extensive review of molecular diagnostic technologies, test formats, detection methodologies,   trends in testing automation and over target/signal amplification methods.

- Worldwide listings of companies, universities and research centers developing new molecular   diagnostic technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants,   including their sales, product portfolios, marketing tactics, collaborative arrangements   and new technologies/products in R&D.

- Abbott Affymetrix Agilent Technologies Applied Gene Technologies Arca Biopharma Beckman Coulter/Danaher Becton Dickinson Biokit bioMerieux Bio-Rad Biotest CellMark Forensics/LabCorp Cepheid Decode Genetics Diadexus Eiken Elitech Group Enzo Exact Sciences Fujirebio Grifols Hologic/Gen-Probe Illumina Kreatech Li-Cor Biosciences Monogram Biosciences/LabCorp Myriad Genetics Ortho-Clinical Diagnostics Perkin Elmer/Caliper Proteome Sciences Qiagen Roche Scienion Sequenom Shimadzu Siemens Sierra Molecular Takara Bio Tecan Group Thermo Fisher

- Comprehensive listings of companies developing and marketing infectious disease molecular   diagnostic products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal   during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Contains 636 pages and 27 tables

Table of Contents

Introduction

Global Market Trends and Emerging Technologies

  • A. DNA Sequencing
  • B. DNA And RNA Probe Technology
  • C. Detection Technologies
  • D. Instrumentation: Review of Automated and Semi-Automated Analyzers
  • E. Biochips: Genosensors, Microarrays, Labs-on-the-Chip
  • F. Pharmacogenomics
  • G. Major Molecular Infectious Diseases Tests
    • AIDS
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Adenovirus/Adeno-Associated Viruses (AAV)
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Anthrax/Bacillus Anthracis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Babesiosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • BEA and Other Bartonella Diseases
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Chagas Disease
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Campylobacter
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Chlamydia
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Creutzfeldt-Jakob's Disease
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Cytomegalovirus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Ebola Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Echovirus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Encephalitis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Enteroviruses
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Epstein-Barr Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Gonorrhea
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Hepatitis A, B, C, D, E, G
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Herpes Simplex Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Legionella
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Lyme Disease
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Malaria
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Mycoplasma
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Papillomaviruses/HPV
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Parvovirus B19
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Pneumonia
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Polyomaviruses
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Salmonellosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Shigellosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Streptococci A, B
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Toxoplasmosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Tuberculosis
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • West Nile Virus
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
    • Yersinia
      • Background
      • Diagnostic Tests
      • Vaccines and Drugs
  • H. Competing/Complementing Technologies

U.S.

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Dynamics, Trends, Size and Growth
    • Volume Forecasts by Test and Market Segment
    • Sales Forecasts by Test and Market Segment
    • Major Supplier Sales and Market Shares

Major Product Development Opportunities

  • A. Opportunities for New Instrumentation
  • B. Opportunities for New Reagent Kits and Test Systems/Panels
  • C. Opportunities for New IT, Computers, Software and Automation
  • D. Opportunities for New Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

Potential Market Entry Barriers And Risks

Competitive Profiles

  • Abbott
  • Affymetrix
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Biotest
  • Caliper
  • Cepheid
  • Decode
  • Diadexus
  • Eiken
  • Enzo
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Grifols
  • Hologic/Gen-Probe
  • Illumina
  • Kreatech
  • Li-Cor Biosciences
  • Life Technologies/Thermo Fisher
  • Monogram Biosciences
  • Myriad Genetics
  • Nanogen/Elitech
  • Orchid CellMark
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • Shimadzu
  • Siemens
  • Sierra Molecular
  • Takara Bio
  • Tecan Group

Appendixes

List of Tables

  • Major Companies Developing or Marketing AIDS Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Adenovirus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Campylobacter Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing CMV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing EBV Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Herpes Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Legionella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Salmonella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Shigella Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Streptococci Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other Direct Identification Tests
  • Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other Direct Identification Tests
  • U.S.A., Laboratories Performing DNA Sequencing by Market Segment
  • U.S.A., Molecular Diagnostics Market, Potential Laboratory Universe by Market Segment
  • U.S.A., Major Infectious Disease Molecular Diagnostics Test Volume Forecast
  • U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
  • U.S.A., Infectious Disease Screening Nat Reagent Market Forecast by Test
  • U.S.A., Molecular Diagnostics Market by Major Supplier
  • U.S.A., HIV/Hepatitis C NAT Market Reagent Sales By Major Supplier
  • U.S.A., West Nile Virus NAT Market Reagent Sales By Major Supplier
Back to Top